Health & Nutrition

bg
Wegovy could prevent up to 1.5 million heart attacks, strokes over 10 years, study says

Wegovy could prevent up to 1.5 million heart attacks, strokes...

The results complement the data Novo Nordisk released last week, which found Wegovy...

bg
Eli Lilly's new price target is above the stock's recent record high. Is this stock a buy?

Eli Lilly's new price target is above the stock's recent...

Questions about price targets come up often and are always worth looking into.

bg
Appeals court imposes restrictions on abortion pill, but drug will stay on the market for now

Appeals court imposes restrictions on abortion pill, but...

The order by the U.S. Court of Appeals for the 5th Circuit is almost certain to...

bg
Toxoplasmosis Prevention 

Toxoplasmosis Prevention 

What are the risks of contracting the brain parasite toxoplasma from cat litter...

bg
Eli Lilly gets a new price target after a big rally. Should I buy more shares?

Eli Lilly gets a new price target after a big rally. Should...

Questions about price targets come up often and are always worth looking into.

bg
Young people are at risk of harsh respiratory problems after 30 days of e-cigarette use, study says

Young people are at risk of harsh respiratory problems...

Researchers urged drug regulators to consider the study findings and work to minimize...

bg
YouTube will remove cancer treatment misinformation

YouTube will remove cancer treatment misinformation

YouTube announced a new policy for combatting medical misinformation on the video...

bg
Jim Cramer talks about his 'favorite stock,' telling investors to buy some as we did last week

Jim Cramer talks about his 'favorite stock,' telling investors...

The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.

bg
The 411 on Blood Pressure

The 411 on Blood Pressure

The number one killer on Earth is a bad diet, and high blood pressure is killer...

bg
SEC investigating Illumina over acquisition of cancer test developer Grail

SEC investigating Illumina over acquisition of cancer test...

Illumina's acquisition of cancer test developer Grail has also faced heavy scrutiny...